MedPath

eurofilament light chains (NFL) in serum in multiple sclerosis for the detection of high risk of disease progressio

Recruiting
Conditions
G35
Multiple sclerosis
Registration Number
DRKS00032567
Lead Sponsor
Klinik und Poliklinik für Neurologie, Universitätsmedizin Mainz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
2000
Inclusion Criteria

Clinically-isolated syndrome or multiple sclerosis according to current McDonald criteria.

Exclusion Criteria

- Factors that contraindicate follow-up examinations as part of the study, e.g., existing pregnancy, florid alcohol abuse, cardiac pacemaker, claustrophobia, implants not capable of MRI
- Patient not capable of giving consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Can NFL predict disease progression(EDA) in NEDA-3 patients.
Secondary Outcome Measures
NameTimeMethod
Can NFL predict PIRA, therapy escalation, MRI changes (T1 black holes, smoldering lesions, brain atrophy). <br>
© Copyright 2025. All Rights Reserved by MedPath